Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C;Purpura thrombotique thrombocytopénique médié par des anticorps anti-ADAMTS13 après un traitement par interféron-alpha 2 a pégylé et ribavirine chez une patiente atteinte d'hépatite C chronique

Presse Medicale

Volumn 39, Issue 11, 2010, Pages 1207-1210

  Lambot, Frédéric ^a   Hanson, Bernard ^a   Sztern, Bernard ^a  

^a Centre Hospitalier Moliere Longchamp   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE INHIBITOR;

HEPATITIS C; HUMAN; LETTER; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 78349304482     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2010.04.016     Document Type: Letter

References (15)

1. Gore I. Disseminated arteriolar and capillary platelet thrombosis; a morphologic study of its histogenesis. Am J Pathol 1950, 26:155-175.
2. Amorosi E., Ultmann J. Thrombotic thrombocytopenic purpura: report 16 cases and reviewof literature. Medicine 1966, 45:139.
3. Moake J.L. Thrombotic microangiopathies. N Engl J Med 2002, 347:589-600.
4. Levy G.G., Nichols W.C., Lian E.C., Foroud T., Mc Clintick J.N., Mc GeeBeth B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001, 413:488-494.
5. Tsai H.M., Raoufi M., Zhou W., Guinto E., Grafos N., Ranzurmal S., et al. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 2006, 95:886-892.
6. Tsai H.M., Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998, 339:1585-1594.
7. Tsai H.M., Rice L., Sarode R., Chow T.W., Moake J.L. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 2000, 132:794.
8. Iyoda K., Kato M., Nakagawa T., Kakiuchi Y., Sugiyasu Y., Fujii E., et al. Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatic C. J Gastroenterol 1998, 33:588-592.
9. Vesely S.K., George J.N., Lammle B., Studt J.D., Alberio L., El-Harake M.A., et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003, 102:60-68.
10. Elefsiniotis I.S., Pantazis K.D., Fotos N.V., Moulakakis A., Mavrogiannis C. Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C. J Gastroenterol Hepatol 2006, 21:622-623.
11. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998, 339:1578-1584.
12. Matsumoto M., Yagi H., Ishizashi H., Wada H., Fujimura Y. The Japanese experience with thrombotic thrombocytopenic purpura/haemolytic-uremic syndrome. Semin Haematol 2004, 41:68-74.
13. Papo T. Interferon alpha et autoimmunité. Rev Med Interne 2002, 23:501s-510s.
14. Rubinstein M.A., Kagan B.M., MacGillviray M.H., Merliss R., Sacks H. Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions. Ann Intern Med 1959, 51:1409-1419.
15. Coppo P., Wolf M., Veyradier A., Bussel A., Malot S., Millot G.A., et al. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol 2006, 132:66-74.